Cargando…

The Prevention of Contrast Induced Nephropathy by Sarpogrelate: a Prospective Randomized Controlled Clinical Trial

BACKGROUND: Although some strategies are used for prophylaxis of contrast induced nephropathy, their efficacy is not fully established. Sarpogrelate can relieve vasospasm and have anti-inflammatory action. This study examined whether sarpogrelate reduces the incidence of contrast induced nephropathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ki, You-Jeong, Kwon, Sun-A, Kim, Hack-Lyoung, Seo, Jae-Bin, Chung, Woo-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801223/ https://www.ncbi.nlm.nih.gov/pubmed/31625293 http://dx.doi.org/10.3346/jkms.2019.34.e261

Ejemplares similares

The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
por: Park, Kyungil, et al.
Publicado: (2010)

Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice
por: Lee, Eun Soo, et al.
Publicado: (2017)

Aspirination of α-Aminoalcohol (Sarpogrelate M1)
por: Park, Sunhwa, et al.
Publicado: (2016)

Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice
por: Kim, Dong-hyun, et al.
Publicado: (2016)

Comparison of endothelial function improvement estimated with reactive hyperemia index between ramipril and telmisartan in hypertensive patients
por: Ki, You-Jeong, et al.
Publicado: (2017)

Prognostic value of reactive hyperemia index using peripheral artery tonometry in patients with heart failure
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Effect of sarpogrelate and high‐dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study
por: Kim, So Ree, et al.
Publicado: (2019)

Effects of sarpogrelate hydrochloride on peripheral arterial disease: A meta-analysis of randomized controlled trials
por: Lu, Yunxin, et al.
Publicado: (2019)

Suppression of high lipid diet induced by atherosclerosis sarpogrelate
por: Xu, Yan-Jun, et al.
Publicado: (2012)

Application of physiologically based pharmacokinetic modeling in predicting drug–drug interactions for sarpogrelate hydrochloride in humans
por: Min, Jee Sun, et al.
Publicado: (2016)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

The Role of ERK1/2 Activation in Sarpogrelate-Mediated Neuroprotection
por: Ku, Cristy A., et al.
Publicado: (2018)

Efficacy of Short-Term High-Dose Statin Pretreatment in Prevention of Contrast-Induced Acute Kidney Injury: Updated Study-Level Meta-Analysis of 13 Randomized Controlled Trials
por: Lee, Joo Myung, et al.
Publicado: (2014)

Novel usage of sarpogrelate hydrochloride in patients with allergy-related variant angina
por: Noma, Kensuke, et al.
Publicado: (2012)

SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial
por: Ahn, Sanghyun, et al.
Publicado: (2017)

A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention
por: Han, Ahram, et al.
Publicado: (2023)

Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results
por: Chen, Yue-Xin, et al.
Publicado: (2015)

Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice
por: Kim, Hack-Lyoung, et al.
Publicado: (2014)

Simultaneously Presented Acute Ischemic Stroke and Non-ST Elevation Myocardial Infarction in a Patient with Paroxysmal Atrial Fibrillation
por: Kim, Hack-Lyoung, et al.
Publicado: (2013)

Impact of atorvastatin reload on the prevention of contrast-induced nephropathy in patients on chronic statin therapy: A prospective randomized trial
por: Hammami, Rania, et al.
Publicado: (2023)

Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level ≥ 190 mg/dL: A retrospective cohort study
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Remote ischemic preconditioning for prevention of contrast-induced nephropathy – A randomized control trial()
por: Bafna, Akshay Ashok, et al.
Publicado: (2020)

Association between arterial stiffness and left ventricular diastolic function in relation to gender and age
por: Kim, Hack-Lyoung, et al.
Publicado: (2017)

Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial
por: Biernacka-Fiałkowska, Barbara, et al.
Publicado: (2018)

Preventive Effect of Pretreatment with Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Angiography (PRINCIPLE Study)
por: Ko, Young-Guk, et al.
Publicado: (2013)

Contrast safety in the cancer patient: preventing contrast-induced nephropathy
por: Heiken, Jay P.
Publicado: (2008)

Effects of sarpogrelate, a 5-hydroxytriptamine 2A receptor antagonist on endotoxin shock in rats
por: Nishiyama, T
Publicado: (2005)

Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice
por: Liu, Hongyang, et al.
Publicado: (2020)

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
por: Fouad Shalaby, Mohammed, et al.
Publicado: (2021)

Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial
por: Huber, Wolfgang, et al.
Publicado: (2016)

The association between arterial stiffness and left ventricular filling pressure in an apparently healthy Korean population
por: Kim, Hack-Lyoung, et al.
Publicado: (2013)

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention
por: Geenen, Remy W. F., et al.
Publicado: (2013)

Prognostic value of serum soluble ST2 in stable coronary artery disease: a prospective observational study
por: Kim, Hack-Lyoung, et al.
Publicado: (2021)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Publicado: (2009)

Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study
por: Choi, Jae Hyuk, et al.
Publicado: (2017)

Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial
por: Iranirad, Leili, et al.
Publicado: (2017)

Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials
por: Sun, Zikai, et al.
Publicado: (2013)

A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy
por: Peruzzi, Mariangela, et al.
Publicado: (2014)

Associations between measurements of central blood pressure and target organ damage in high-risk patients
por: Jeon, Ki-Hyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_218rdqglieqpkjkb577h1fi0n8